R E Sampliner

University of Arizona

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Ronnie Fass

MetroHealth Medical Center

Stuart J. Spechler

Baylor University Medical Center

Lee L. Swanström

Institut de Chirurgie Guidée par l'Image

Brant K. Oelschlager

University of Washington

Manuel Pera

Hospital Del Mar

Thomas A. D’Amico

Duke Medical Center

Long-Qi Chen

Sichuan University

Sri Komanduri

Northwestern University

Daniel Sifrim

Queen Mary University of London

John M. Wo

Indiana University – Purdue University Indianapolis

Cooperative Institutions

John Wiley & Sons (United States)

University of Arizona

Southern Arizona VA Health Care System

United States Department of Veterans Affairs

National Institutes of Health

Johns Hopkins University

Banner - University Medical Center Tucson

Oregon Health & Science University

Johns Hopkins Medicine

University Gastroenterology

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Limitations of fecal occult blood testing

Archives of Internal Medicine (1990)

R E Sampliner

The medical literature is replete with studies of fecal occult blood tests, as documented in the references of the articles by Stelling et al¹andSee also pp 1001 and 1041. Ahlquist et al²in this issue of theArchives. Much of the assessment of fecal occult blood testing has been in the area of screening for colorectal carcinoma, a subject recently well reviewed.^3,4Ahlquist et al²emphasize that even with the use of HemoQuant, a sensitive measure of gastrointestinal (GI) tract bleeding, 41% of patients with symptomatic colorectal cancers had a negative result of a fecal occult blood test. In relation to other tests, HemoQuant requires greater stool sampling. This study is limited by its retrospective nature and failure to define why 40 patients did not qualify. An interesting finding was significantly higher positivity when testing was performed before bowel preparation for diagnostic studies. The

Fecal occult blood

Occult

Blood testing

10.1001/archinte.150.5.945

Cite

Citations (1)

Short Segment Barrett's Esophagus—The Need for Standardization of the Definition and of Endoscopic Criteria

The American Journal of Gastroenterology (1998)

Prateek Sharma T G Morales R E Sampliner

There has been a recent increase in abstracts and publications reporting intestinal metaplasia in the distal esophagus and cardia. The terms “short segment Barrett's esophagus,”“intestinal metaplasia of the esophagogastric junction,” and “intestinal metaplasia of the cardia” are being used to describe either similar or different entities. This review article deals with the current data on these issues, the definition of short segment Barrett's esophagus including the endoscopic and histologic criteria, the rationale for separating short segment Barrett's esophagus from intestinal metaplasia of the cardia, and a simple classification of intestinal metaplasia.

Intestinal metaplasia

Metaplasia

Barrett's esophagus

Esophagogastric junction

GASTRIC CARDIA

10.1111/j.1572-0241.1998.00324.x

Cite

Citations (293)

Diseases of the Esophagus (2015)

André Duranceau John E. Pandolfino Kemper Wray Brant K. Oelschlager Donald E. Low

10.1111/dote.2015.28.issue-5

Cite

Citations (1)

Management of premalignant esophagogastric lesions.

PubMed (1982)

R E Sampliner

Esophagogastric junction

Precancerous condition

Source

Cite

Citations (2)

The prevalence of barretts esophagus in hispanic patients undergoing endoscopy is similar to causasian patients

Gastrointestinal Endoscopy (1997)

Korina Bersentes Sukhdeep Padda Harinder S. Garewal R E Sampliner Robert J. Fass

10.1016/s0016-5107(97)80157-5

Cite

Citations (0)

Variceal heavyweights: the ring versus the needle.

PubMed (1993)

F Faris R E Sampliner

Source

Cite

Citations (0)

Barrett's oesophagus and development of dysplasia and adenocarcinoma.

Gut (1993)

Frank Faris R E Sampliner

stones or more than one stone.The paper fails to make any comment on symptom relief, however, and the surprising result of our lithotripsy trial' was that the symptoms were relieved, just as much as after cholecystectomy, within the first month of treatment, well before any stones had disappeared; and the pain relief for the whole year and the relief of many other symptoms did not depend on stone clearance: so we have to distinguish between success in terms of stone clearance and success in terms of symptom relief.Lithotripsy, for whatever reason seems a very cost effective way of doing the second, at least in the short term.We are at present following up our patients for longer periods to see if this symptom improvement is maintained.

Barrett's oesophagus

Premalignant lesion

10.1136/gut.34.9.1292-a

Cite

Citations (0)

Screening for Barrett's esophagus by balloon cytology.

PubMed (1995)

M. Brian Fennerty John P. DiTomasso T G Morales Danielle F. Peterson Anirban Karmakar

to determine whether balloon cytology would allow a nonendoscopic diagnosis of Barrett's esophagus.In 10 unselected patients with Barrett's esophagus, balloon cytology was performed with a Brandt esophageal cytology balloon catheter prior to endoscopy/esophageal biopsy. Specimens were cytologically evaluated for the presence of goblet cells and/or dysplasia.No patient had goblet cells or definitive columnar cell dysplasia.This technique with a commercially available balloon catheter does not allow for a nonendoscopic diagnosis of Barrett's esophagus.

Barrett's esophagus

Balloon catheter

Esophageal disease

Source

Cite

Citations (30)

Issue Information

Diseases of the Esophagus (2014)

André Duranceau John E. Pandolfino Karen Horan Brant K. Oelschlager Donald E. Low

10.1111/dote.12140

Cite

Citations (0)